TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07334262: A Study to Evaluate the Food Effect on the Pharmacokinetics of RNK08954 Tablets and to Assess the Mass Balance of [14C]RNK08954 in Healthy Adult Male Subjects in China

Sponsor: Ranok Therapeutics (Hangzhou) Co., Ltd. · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 24 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$4,131,408

Rescue Site Savings

+$2,731,696

Unlock Full NCT07334262 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07334262 Rescue Dossier →